Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction. Yuan J, Sun Y, Wang K, Wang Z, et al. BMC Cancer 2022;22:686.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yuan J, Sun Y, Wang K, Wang Z, et al. Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction. BMC Cancer 2022;22:686.
PMID: 35729538